Purpose
We determined whether scores on a cognitive screening measure were associated with the primary outcome measure of peak walking time (PWT) and with secondary outcome measures related to mobility, community-based ambulation, health-related quality of life (QoL), and vascular function in patients with claudication and PAD.
Methods
Gross cognitive status of 246 PAD patients was assessed with the Mini-Mental State Examination (MMSE) questionnaire. Patients were grouped according to whether they had a perfect MMSE score of 30 points (n=123) or whether they missed one or more points (n=123). Patients were characterized on numerous outcomes, including PWT during a treadmill test and QoL.
Results
Compared to the Higher MMSE group, there was a trend for lower PWT in the Lower MMSE group (p=.06) after adjusting for age, sex, race, and education level (model 1), which became significant (380±250 s vs. 460±270 s, p<.05) after adjusting for model 1 plus coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), and arthritis (model 2). Multiple domains of QoL were lower (p<.05) in the Lower MMSE group after adjusting for model 1, but only mental health remained lower (75±20% vs. 80±5%, p=.02) after further adjustment with model 2.
Conclusions
In symptomatic patients with PAD, lower cognitive screening scores were associated with greater ambulatory impairment than in patients with higher MMSE scores. Furthermore, worse cognitive status was associated with lower scores in multiple dimensions of health-related QoL, all of which except mental health were explained by the comorbid conditions of CAD, COPD, and arthritis. The clinical significance is that there is a need for enhanced cognitive and mental health screening as potential indicators of poor outcome among symptomatic patients with PAD. Furthermore, patients identified as having worse cognitive status may be in greatest need of intervention to improve ambulation and quality of life related to mental health.